{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:42:34Z","timestamp":1792010554795,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7507","license":[{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T00:00:00Z","timestamp":1400630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2014,7,3]]},"DOI":"10.1038\/nature13297","type":"journal-article","created":{"date-parts":[[2014,5,21]],"date-time":"2014-05-21T05:52:16Z","timestamp":1400651536000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":238,"title":["Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones"],"prefix":"10.1038","volume":"511","author":[{"given":"Juan Pablo","family":"Maianti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"McFedries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachariah H.","family":"Foda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Quan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm A.","family":"Leissring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen J.","family":"Charron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A.","family":"Seeliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Saghatelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,21]]},"reference":[{"key":"BFnature13297_CR1","first-page":"608","volume":"19","author":"WC Duckworth","year":"1998","unstructured":"Duckworth, W. C., Bennett, R. G. & Hamel, F. G. Insulin degradation: progress and potential. Endocr. Rev. 19, 608\u2013624 (1998)","journal-title":"Endocr. Rev."},{"key":"BFnature13297_CR2","first-page":"1","volume":"20","author":"IA Mirsky","year":"1949","unstructured":"Mirsky, I. A. & Broh-Kahn, R. H. The inactivation of insulin by tissue extracts; the distribution and properties of insulin inactivating extracts. Arch. Biochem. 20, 1\u20139 (1949)","journal-title":"Arch. Biochem."},{"key":"BFnature13297_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05616","volume":"445","author":"R Sladek","year":"2007","unstructured":"Sladek, R. et al. A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881\u2013885 (2007)","journal-title":"Nature"},{"key":"BFnature13297_CR4","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1126\/science.1142364","volume":"316","author":"E Zeggini","year":"2007","unstructured":"Zeggini, E. et al. Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336\u20131341 (2007)","journal-title":"Science"},{"key":"BFnature13297_CR5","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1073\/pnas.0230450100","volume":"100","author":"W Farris","year":"2003","unstructured":"Farris, W. et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc. Natl Acad. Sci. USA 100, 4162\u20134167 (2003)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13297_CR6","doi-asserted-by":"publisher","first-page":"e20818","DOI":"10.1371\/journal.pone.0020818","volume":"6","author":"SO Abdul-Hay","year":"2011","unstructured":"Abdul-Hay, S. O. et al. Deletion of insulin-degrading enzyme elicits antipodal, age-dependent effects on glucose and insulin tolerance. PLoS ONE 6, e20818 (2011)","journal-title":"PLoS ONE"},{"key":"BFnature13297_CR7","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1126\/science.1102629","volume":"305","author":"ZJ Gartner","year":"2004","unstructured":"Gartner, Z. J. et al. DNA-templated organic synthesis and selection of a library of macrocycles. Science 305, 1601\u20131605 (2004)","journal-title":"Science"},{"key":"BFnature13297_CR8","doi-asserted-by":"publisher","first-page":"15611","DOI":"10.1021\/ja805649f","volume":"130","author":"BN Tse","year":"2008","unstructured":"Tse, B. N., Snyder, T. M., Shen, Y. & Liu, D. R. Translation of DNA into a library of 13,000 synthetic small-molecule macrocycles suitable for in vitro selection. J. Am. Chem. Soc. 130, 15611\u201315626 (2008)","journal-title":"J. Am. Chem. Soc."},{"key":"BFnature13297_CR9","doi-asserted-by":"publisher","first-page":"8523","DOI":"10.1073\/pnas.1203195109","volume":"109","author":"YG Kim","year":"2012","unstructured":"Kim, Y. G., Lone, A. M., Nolte, W. M. & Saghatelian, A. Peptidomics approach to elucidate the proteolytic regulation of bioactive peptides. Proc. Natl Acad. Sci. USA 109, 8523\u20138527 (2012)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13297_CR10","doi-asserted-by":"publisher","first-page":"e10504","DOI":"10.1371\/journal.pone.0010504","volume":"5","author":"MA Leissring","year":"2010","unstructured":"Leissring, M. A. et al. Designed inhibitors of insulin-degrading enzyme regulate the catabolism and activity of insulin. PLoS ONE 5, e10504 (2010)","journal-title":"PLoS ONE"},{"key":"BFnature13297_CR11","doi-asserted-by":"publisher","first-page":"12822","DOI":"10.1021\/bi801192h","volume":"47","author":"E Malito","year":"2008","unstructured":"Malito, E. et al. Molecular bases for the recognition of short peptide substrates and cysteine-directed modifications of human insulin-degrading enzyme. Biochemistry 47, 12822\u201312834 (2008)","journal-title":"Biochemistry"},{"key":"BFnature13297_CR12","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1007\/s00018-008-8112-4","volume":"65","author":"E Malito","year":"2008","unstructured":"Malito, E., Hulse, R. E. & Tang, W. J. Amyloid beta-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin. Cell. Mol. Life Sci. 65, 2574\u20132585 (2008)","journal-title":"Cell. Mol. Life Sci."},{"key":"BFnature13297_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/nature05143","volume":"443","author":"Y Shen","year":"2006","unstructured":"Shen, Y., Joachimiak, A., Rosner, M. R. & Tang, W. J. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Nature 443, 870\u2013874 (2006)","journal-title":"Nature"},{"key":"BFnature13297_CR14","doi-asserted-by":"publisher","first-page":"14177","DOI":"10.1074\/jbc.M900068200","volume":"284","author":"M Manolopoulou","year":"2009","unstructured":"Manolopoulou, M., Guo, Q., Malito, E., Schilling, A. B. & Tang, W. J. Molecular basis of catalytic chamber-assisted unfolding and cleavage of human insulin by human insulin-degrading enzyme. J. Biol. Chem. 284, 14177\u201314188 (2009)","journal-title":"J. Biol. Chem."},{"key":"BFnature13297_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/0192623307310945","volume":"36","author":"VJ Stella","year":"2008","unstructured":"Stella, V. J. & He, Q. Cyclodextrins. Toxicol. Pathol. 36, 30\u201342 (2008)","journal-title":"Toxicol. Pathol."},{"key":"BFnature13297_CR16","doi-asserted-by":"publisher","first-page":"E1323","DOI":"10.1152\/ajpendo.90617.2008","volume":"295","author":"S Andrikopoulos","year":"2008","unstructured":"Andrikopoulos, S., Blair, A. R., Deluca, N., Fam, B. C. & Proietto, J. Evaluating the glucose tolerance test in mice. Am. J. Physiol. Endocrinol. Metab. 295, E1323\u2013E1332 (2008)","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnature13297_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1677\/JOE-07-0460","volume":"197","author":"B Ahr\u00e9n","year":"2008","unstructured":"Ahr\u00e9n, B., Winzell, M. S. & Pacini, G. The augmenting effect on insulin secretion by oral versus intravenous glucose is exaggerated by high-fat diet in mice. J. Endocrinol. 197, 181\u2013187 (2008)","journal-title":"J. Endocrinol."},{"key":"BFnature13297_CR18","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.2337\/diabetes.53.suppl_3.S215","volume":"53","author":"MS Winzell","year":"2004","unstructured":"Winzell, M. S. & Ahren, B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53 (Suppl 3). S215\u2013S219 (2004)","journal-title":"Diabetes"},{"key":"BFnature13297_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker, D. J. The biology of incretin hormones. Cell Metab. 3, 153\u2013165 (2006)","journal-title":"Cell Metab."},{"key":"BFnature13297_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2337\/diacare.29.02.06.dc05-1267","volume":"29","author":"MC Riddle","year":"2006","unstructured":"Riddle, M. C. & Drucker, D. J. Emerging therapies mimicking the effects of amylin and glucagon-like peptide 1. Diabetes Care 29, 435\u2013449 (2006)","journal-title":"Diabetes Care"},{"key":"BFnature13297_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00003495-199957010-00003","volume":"57","author":"AD Mooradian","year":"1999","unstructured":"Mooradian, A. D. & Thurman, J. E. Drug therapy of postprandial hyperglycaemia. Drugs 57, 19\u201329 (1999)","journal-title":"Drugs"},{"key":"BFnature13297_CR22","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2337\/diab.23.6.536","volume":"23","author":"WC Duckworth","year":"1974","unstructured":"Duckworth, W. C. & Kitabchi, A. E. Insulin and glucagon degradation by the same enzyme. Diabetes 23, 536\u2013543 (1974)","journal-title":"Diabetes"},{"key":"BFnature13297_CR23","doi-asserted-by":"publisher","first-page":"36621","DOI":"10.1074\/jbc.M006170200","volume":"275","author":"RG Bennett","year":"2000","unstructured":"Bennett, R. G., Duckworth, W. C. & Hamel, F. G. Degradation of amylin by insulin-degrading enzyme. J. Biol. Chem. 275, 36621\u201336625 (2000)","journal-title":"J. Biol. Chem."},{"key":"BFnature13297_CR24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S1054-3589(05)52010-6","volume":"52","author":"A Young","year":"2005","unstructured":"Young, A. Effects on plasma glucose and lactate. Adv. Pharmacol. 52, 193\u2013208 (2005)","journal-title":"Adv. Pharmacol."},{"key":"BFnature13297_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.regpep.2006.06.004","volume":"137","author":"BR Gedulin","year":"2006","unstructured":"Gedulin, B. R., Jodka, C. M., Herrmann, K. & Young, A. A. Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187. Regul. Pept. 137, 121\u2013127 (2006)","journal-title":"Regul. Pept."},{"key":"BFnature13297_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling, R. W. et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl Acad. Sci. USA 100, 1438\u20131443 (2003)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnature13297_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1172\/JCI60016","volume":"122","author":"RH Unger","year":"2012","unstructured":"Unger, R. H. & Cherrington, A. D. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J. Clin. Invest. 122, 4\u201312 (2012)","journal-title":"J. Clin. Invest."},{"key":"BFnature13297_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrendo.2013.47","volume":"9","author":"SA Sadry","year":"2013","unstructured":"Sadry, S. A. & Drucker, D. J. Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. Nature Rev. Endocrinol. 9, 425\u2013433 (2013)","journal-title":"Nature Rev. Endocrinol."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nature13297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature13297","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nature13297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T16:30:18Z","timestamp":1630686618000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nature13297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,21]]},"references-count":28,"journal-issue":{"issue":"7507","published-print":{"date-parts":[[2014,7,3]]}},"alternative-id":["BFnature13297"],"URL":"https:\/\/doi.org\/10.1038\/nature13297","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718408816.793495573","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718408816.793497037","asserted-by":"object"}]},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,21]]},"assertion":[{"value":"9 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.M., A.S. and D.R.L. are co-inventors on a provisional patent application that describes the discovery and properties of <b>6bK<\/b>.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}